A single-point mutation (Ala280Val) in the third intracellular loop alters the signalling properties of the human histamine H? receptor stably expressed in CHO-K1 cells.
Ontology highlight
ABSTRACT: BACKGROUND AND PURPOSE: An alanine to valine exchange at amino acid position 280 (A280V) in the third intracellular loop of the human histamine H? receptor was first identified in a patient suffering from Shy-Drager syndrome and later reported as a risk factor for migraine. Here, we have compared the pharmacological and signalling properties of wild-type (hH? R(WT)) and A280V mutant (hH? R(A280V)) receptors stably expressed in CHO-K1 cells. EXPERIMENTAL APPROACH: The hH? R(A280V) cDNA was created by overlapping extension PCR amplification. Receptor expression and affinity were assessed by radioligand (N-?-[methyl-³H]-histamine) binding to cell membranes, and receptor function by the inhibition of forskolin-induced cAMP accumulation and stimulation of ERK1/2 phosphorylation in intact cells, as well as stimulation of [³?S]-GTP?S binding to cell membranes. KEY RESULTS: Both receptors were expressed at similar levels with no significant differences in their affinities for H? receptor ligands. Upon activation the hH? RWT was significantly more efficacious to inhibit forskolin-induced cAMP accumulation and to stimulate [³?S]-GTP?S binding, with no difference in pEC50 estimates. The hH? RWT was also more efficacious to stimulate ERK1/2 phosphorylation, but this difference was not significant. The inverse agonist ciproxifan was more efficacious at hH3 RWT to reduce [³?S]-GTP?S binding but, for both receptors, failed to enhance forskolin-induced cAMP accumulation. CONCLUSIONS AND IMPLICATIONS: The A280V mutation reduces the signalling efficacy of the human H? receptor. This effect may be relevant to the pathophysiology of disorders associated with the mutation.
SUBMITTER: Flores-Clemente C
PROVIDER: S-EPMC3764854 | biostudies-other | 2013 Sep
REPOSITORIES: biostudies-other
ACCESS DATA